0341 GMT - Life360 has the flexibility to manage potential dilution from its convertible note offering, MS analysts say. They tell clients that the tracking-app provider's raise strengthens its balance sheet through to fiscal 2030 at a very attractive rate. The trade-off is potential dilution if the dual-listed company's U.S. stock passes US$122.22 a share. They think that the structure of the notes and the strength of performance that would be required for the stock to trade at such levels provide Life360 with options to manage the scenario. MS has an overweight recommendation and A$32.00 target price on Life360's Australia-listed shares, which are down 1.7% at A$32.675. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
June 09, 2025 23:41 ET (03:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。